Sjlee: 새 문서: # 질병관리본부. 우리나라 성병 감시체계 및 국내 발생 현황. 질병관리본부; 2008. # 임균감염증#cite ref-.ED.95.9C.EA.B5.AD.EC.97.90.EC.84.9C .EB.B6.84...

2019-06-28T07:00:42Z

새 문서: # 질병관리본부. 우리나라 성병 감시체계 및 국내 발생 현황. 질병관리본부; 2008. # 임균감염증#cite ref-.ED.95.9C.EA.B5.AD.EC.97.90.EC.84.9C .EB.B6.84...

새 문서

# 질병관리본부. 우리나라 성병 감시체계 및 국내 발생 현황. 질병관리본부; 2008.
# [[임균감염증#cite ref-.ED.95.9C.EA.B5.AD.EC.97.90.EC.84.9C .EB.B6.84.EB.A6.AC.EB.90.9C .281999-2002.29 .EC.9E.84.EA.B7.A0.EC.9D.98 .ED.95.AD.EA.B7.A0.EC.A0.9C .EB.82.B4.EC.84.B1.EC.96.91.EC.83.81.EA.B3.BC ciprofloxacin .EB.82.B4.EC.84.B1.EA.B7.A0.EC.9D.98 .ED.8A.B9.EC.84.B1.EC.97.B0.EA.B5.AC 2-0|이동↑]] 유정식, 유천권, 조윤주, 박현정, 오희복, 성원근. 한국에서 분리된 (1999-2002) 임균의 항균제 내성양상과 ciprofloxacin 내성균의 특성연구. 질병관리본부; 2003.
# ↑ [[임균감염증#cite ref-.EA.B5.AD.EB.82.B4.EC.97.90.EC.84.9C .EB.B6.84.EB.A6.AC.EB.90.98.EB.8A.94 .EC.9E.84.EA.B7.A0.EC.9D.98 .ED.95.AD.EA.B7.A0.EC.A0.9C .EB.82.B4.EC.84.B1 3-0|이동:3.0]] [[임균감염증#cite ref-.EA.B5.AD.EB.82.B4.EC.97.90.EC.84.9C .EB.B6.84.EB.A6.AC.EB.90.98.EB.8A.94 .EC.9E.84.EA.B7.A0.EC.9D.98 .ED.95.AD.EA.B7.A0.EC.A0.9C .EB.82.B4.EC.84.B1 3-1|3.1]] 질병관리본부. 국내에서 분리되는 임균의 항균제 내성. 질병관리본부; 2007.
# [[임균감염증#cite ref-Sexually transmitted diseases surveillance 2007 4-0|이동↑]] Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2007: National profile. P17-18.
# [[임균감염증#cite ref-Update to CDC.27s Sexually Transmitted Diseases Treatment Guidelines.2C 2006 5-0|이동↑]] Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections. ,2007;56:332–336.
# [[임균감염증#cite ref-Surveillance and Epidemiology Section.2C Community Acquired Infections Division.2C Public Health Agency of Canada.2C 2006. 6-0|이동↑]] Unpublished data. Surveillance and Epidemiology Section, Community Acquired Infections Division, Public Health Agency of Canada, 2006.
# ↑ [[임균감염증#cite ref-Gonorrhea treatment guidelines in Canada: 2004 update. 7-0|이동:7.0]] [[임균감염증#cite ref-Gonorrhea treatment guidelines in Canada: 2004 update. 7-1|7.1]] Mann J, Kropp R, Wong T, et al. Gonorrhea treatment guidelines in Canada: 2004 update. CMAJ 2004;171:1345–1346.
# [[임균감염증#cite ref-World Health Organization Regional Office for the Western pacific. Consensus report on STI.2C HIV and AIDS epidemiology Philippines 2002. 8-0|이동↑]] World Health Organization Regional Office for the Western pacific. Consensus report on STI, HIV and AIDS epidemiology Philippines 2002. Department of Health Philippines.
# [[임균감염증#cite ref-The gonococcal antimicrobial surveillance programme .28GASP.29 of the WHO Western Pacific region present trends. 9-0|이동↑]] World Health Organization Regional Office for the Western Pacific. The gonococcal antimicrobial surveillance programme (GASP) of the WHO Western Pacific region present trends. Surveillance Reports 17:13-15, 2002.
# [[임균감염증#cite ref-Sexually transmitted diseases and travel. 10-0|이동↑]] Memish ZA, Osoba AO. Sexually transmitted diseases and travel. Int J Antimicrob Agents 2003;21:131-134.
# [[임균감염증#cite ref-Continuing evolution of the pattern of quinolone resistance in Neisseria gonorrhoeae isolated in Sydney.2C Australia. 11-0|이동↑]] Tapsall JW, Limnios EA, Shultz TR. Continuing evolution of the pattern of quinolone resistance in Neisseria gonorrhoeae isolated in Sydney, Australia. Sex Transm Dis 1998;25:415–417.
# [[임균감염증#cite ref-Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. 12-0|이동↑]] Ng LK, Sawatzky P, Martin IE, et al. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. Sex Transm Dis 2002;29:780-788.
# [[임균감염증#cite ref-Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women.3B results from a cohort study. 13-0|이동↑]] Laga M, Manoka A, Kivuvu M, et al. Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women; results from a cohort study. AIDS 1993;7:95-102.
# [[임균감염증#cite ref-Laboratory-acquired gonococcal conjunctivitis. 14-0|이동↑]] Bruins SC, Tight RR. Laboratory-acquired gonococcal conjunctivitis. JAMA 1979; 241:274-279.
# [[임균감염증#cite ref-Complication after ocular contamination with urine. 15-0|이동↑]] Valenton MJ, Abendanio R. Gonococcal conjunctivitis. Complication after ocular contamination with urine. Can J Ophthalmol 1973;8:421-425.
# [[임균감염증#cite ref-System of Ophthalmology 16-0|이동↑]] Duke-Elder S. System of Ophthalmology, 1st ed. Vol. 8. St Louis: Mosby, 1965;167-174.
# [[임균감염증#cite ref-Destructive epidemic Neisseria gonorrhoeae keratoconjunctivitis in African adults. 17-0|이동↑]] Larryschwab, Teferra T. Destructive epidemic Neisseria gonorrhoeae keratoconjunctivitis in African adults. Br J Ophthalmol 1985;69:525-528.
# ↑ [[임균감염증#cite ref-Gonococcal arthritis. 18-0|이동:18.0]] [[임균감염증#cite ref-Gonococcal arthritis. 18-1|18.1]] Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol 17:201-208, 2003.
# [[임균감염증#cite ref-Neisseria Gonorrhoeae 19-0|이동↑]] Sparling PF, Handsfield HH. Neisseria Gonorrhoeae, In: Douglas, and Bennett's Principles and Practice of Infectious Diseases 5th ed. 22422258, United States, Churchill Livingstone, 2000.
# ↑ [[임균감염증#cite ref-Gonococcal arthritis 20-0|이동:20.0]] [[임균감염증#cite ref-Gonococcal arthritis 20-1|20.1]] Cucurull E, Espinoza LR : Gonococcal arthritis. Rheum Dis Clin North Am 24:305-322, 1998
# [[임균감염증#cite ref-Disseminated gonococcal infection in three adolescents. 21-0|이동↑]] Guinto-Ocampo H, Friedland LR : Disseminated gonococcal infection in three adolescents. Pediatr Emerg Care 17:441-443, 2001.
# [[임균감염증#cite ref-Gonorrhea: a pediatric perspective. 22-0|이동↑]] Sung L, MacDonald NE. Gonorrhea: a pediatric perspective. Pediatr Rev 1998;19:13–22.
# [[임균감염증#cite ref-What proportion of episodes of gonorrhea and chlamydia become symptomatic.3F 23-0|이동↑]] Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhea and chlamydia become symptomatic? Int J STD AIDS 2002; 13:91-101.
# [[임균감염증#cite ref-Clinical aspects of diagnosis of gonorrhea and chlamydia infection in an acute care setting. 24-0|이동↑]] Mehta SD, Rothman RE, Kelen GD, Quinn TC, Zenilman JM. Clinical aspects of diagnosis of gonorrhea and chlamydia infection in an acute care setting. Clin Infect Dis 2001;32:655–659.
# [[임균감염증#cite ref-Microbiological diagnosis of gonorrhoea. 25-0|이동↑]] Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourin Med 1997;73:245-252.
# [[임균감염증#cite ref-Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections 26-0|이동↑]] Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections — 2002. MMWR Recomm Rep 2002;51(RR-15):1–38.
# [[임균감염증#cite ref-Systematic Review: Non-invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. 27-0|이동↑]] Cook RL, Hutchison SL, Østergaard L, et al. Systematic Review: Non-invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142:914-925.
# [[임균감염증#cite ref-Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay.2C culture and three nucleic acid amplification tests 28-0|이동↑]] Van Dyck E, Ieven M, Pattyn S, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. J Clin Microbiol 2001;39:1751-1756.
# [[임균감염증#cite ref-AATs: is the time right.3F Sex Transm Infect 29-0|이동↑]] Ison C. GC NAATs: is the time right? Sex Transm Infect 2006;82:515.
# [[임균감염증#cite ref-Guidance on the Introduction of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories. 30-0|이동↑]] HPS, Scottish Bacterial STIs Reference Laboratory. Guidance on the Introduction of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories. 01 Aug 2007.
# [[임균감염증#cite ref-Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: A position paper on behalf of the Public Health Laboratory Network 31-0|이동↑]] Smith DW, Tapsall JW, Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: A position paper on behalf of the Public Health Laboratory Network. Communicable Diseases Intelligence 2005;29: 358-365.
# [[임균감염증#cite ref-Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonrrhoea in men who have sex with men. 32-0|이동↑]] Page-Shafer K, Graves A, Kent C, et al. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonrrhoea in men who have sex with men. Clinical Infectious Diseases 2002;34:173-176.
# [[임균감염증#cite ref-Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men. 33-0|이동↑]] McNally LP, Templeton DJ, Jin F, et al. Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men. Clin Infect Dis 2008 Jul 15;47(2):e25-e27.
# [[임균감염증#cite ref-Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. 34-0|이동↑]] Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003;41:304-309.
# ↑ [[임균감염증#cite ref-Gonorrhoea in men: clinical and diagnostic aspects. 35-0|이동:35.0]] [[임균감염증#cite ref-Gonorrhoea in men: clinical and diagnostic aspects. 35-1|35.1]] Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996;72:422426.
# [[임균감염증#cite ref-Gonorrhoea in women: diagnostic.2C clinical and laboratory aspects. 36-0|이동↑]] Barlow D, Phillips I. Gonorrhoea in women: diagnostic, clinical and laboratory aspects. Lancet 1978;i:761-764.
# [[임균감염증#cite ref-Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. 37-0|이동↑]] Lyss SB, Kamb ML, Peterman TA, et al; Project RESPECT Study Group. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003;139:178-185.
# [[임균감염증#cite ref-What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic.3F 38-0|이동↑]] Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002;13:91-101.
# [[임균감염증#cite ref-The Gonococcal Resistance to Antimicrobials Programme .28GRASP.29 Year 2007 report. 39-0|이동↑]] GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Programme (GRASP) Year 2007 report. London: Health Protection Agency 2008.
# [[임균감염증#cite ref-Chlamydia trachomatis and Neisseria gonorrhoeae Prevalence and Coinfection in Adolescents Entering Selected US Juvenile Detention Centers 40-0|이동↑]] KAHN RH, MOSURE DJ, BLANK S, et al. Chlamydia trachomatis and Neisseria gonorrhoeae Prevalence and Coinfection in Adolescents Entering Selected US Juvenile Detention Centers, 1997–2002. Sex Transm Dis 2005;32:255-259.
# [[임균감염증#cite ref-Antimicrobial resistance patterns .281999-2002.29 and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea. 41-0|이동↑]] Yoo J, Yoo C, Cho Y, et al. Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea. Sex Transm Dis 2004;31:305-10.
# ↑ [[임균감염증#cite ref-Global resistance of Neisseria gonorrhoeae: when theory becomes reality. 42-0|이동:42.0]] [[임균감염증#cite ref-Global resistance of Neisseria gonorrhoeae: when theory becomes reality. 42-1|42.1]] Lewis DA. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.Curr Opin Infect Dis. 2014 Feb;27(1):62-7.
# ↑ [[임균감염증#cite ref-Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past.2C evolution.2C and future. 43-0|이동:43.0]] [[임균감염증#cite ref-Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past.2C evolution.2C and future. 43-1|43.1]] Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014 Jul;27(3):587-613.
# ↑ [[임균감염증#cite ref-Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae 44-0|이동:44.0]] [[임균감염증#cite ref-Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae 44-1|44.1]] Muratani T, Inatomi H, Ando Y et al. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. Int J Urol. 2008;15:837-42.
# ↑ [[임균감염증#cite ref-Gonococcal infection. Sexually transmitted infections.2C diagnosis and treatment guidelines 2011 45-0|이동:45.0]] [[임균감염증#cite ref-Gonococcal infection. Sexually transmitted infections.2C diagnosis and treatment guidelines 2011 45-1|45.1]] Japanese Society of Sexually Transmitted Infection. 2011. Gonococcal infection. Sexually transmitted infections, diagnosis and treatment guidelines 2011. Jpn. J. Sex. Transm. Dis. 22(Suppl 1):52–59. (In Japanese.)
# ↑ [[임균감염증#cite ref-The Presentation.2C Diagnosis.2C and Treatment of Sexually Transmitted Infections. 46-0|이동:46.0]] [[임균감염증#cite ref-The Presentation.2C Diagnosis.2C and Treatment of Sexually Transmitted Infections. 46-1|46.1]] Wagenlehner FM, Brockmeyer NH, Discher T, Friese K, Wichelhaus TA.The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections.Dtsch Arztebl Int. 2016 Jan 11;113(1-02):11-22.
# [[임균감염증#cite ref-Sexually transmitted disease surveillance 2013 47-0|이동↑]] CDC. Sexually transmitted disease surveillance 2013. Atlanta: US Department of Health and Human Services; 2014.
# [[임균감염증#cite ref-New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae 48-0|이동↑]] Lee H, Lee K, Chong Y. New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2016 Feb;14(2):243-56.
# [[임균감염증#cite ref-Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options.2C 49-0|이동↑]] Kirkcaldy RD. 2013. Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options, abstr SO8.1. STI AIDS World Cong. 2013, 14 to 17 July 2013, Vienna, Austria.
# [[임균감염증#cite ref-Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe.2C Malawi.2C 2007 50-0|이동↑]] Brown LB, Krysiak R, Kamanga G, Mapanje C, Kanyamula H, Banda B, Mhango C, Hoffman M, Kamwendo D, Hobbs M, Hosseinipour MC, Martinson F, Cohen MS, Hoffman IF. 2010. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex. Transm. Dis. 37:169 –172.
# [[임균감염증#cite ref-Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin.3F 51-0|이동↑]] Ross JD, Lewis DA. 2012. Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin? Sex. Transm. Infect. 88:6-8.
# [[임균감염증#cite ref-An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. 52-0|이동↑]] Chisholm SA, Quaye N, Cole MJ, Fredlund H, Hoffmann S, Jensen JS, van de Laar MJ, Unemo M, Ison CA. 2011. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J. Antimicrob. Chemother. 66:592–595.
# [[임균감염증#cite ref-Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options 53-0|이동↑]] Kirkcaldy RD. 2013. Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options, abstr SO8.1. STI AIDS World Cong. 2013, 14 to 17 July 2013, Vienna, Austria.
# ↑ [[임균감염증#cite ref-Update on the Management of Gonorrhoea in Adults in the United States. 54-0|이동:54.0]] [[임균감염증#cite ref-Update on the Management of Gonorrhoea in Adults in the United States. 54-1|54.1]] Newman LM, Moran JS, Workowski KA. Update on the Management of Gonorrhoea in Adults in the United States. Clin Infect Dis 2007;44:S84-101.
# [[임균감염증#cite ref-Drugs of choice for the treatment of uncom.C2.ADplicated gonococcal infections. 55-0|이동↑]] Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995;20(Suppl 1):S47-S65.
# ↑ [[임균감염증#cite ref-Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important.3F 56-0|이동:56.0]] [[임균감염증#cite ref-Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important.3F 56-1|56.1]] [[임균감염증#cite ref-Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important.3F 56-2|56.2]] Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Trans Dis 1995;22:39-47.
# [[임균감염증#cite ref-A randomised trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhoea in pregnancy. 57-0|이동↑]] Ramus RM, Sheffield JS, Mayfield JA, Wendel GD. A randomised trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhoea in pregnancy. Am J Obstet Gynecol 2001;185:629-632.
# [[임균감염증#cite ref-Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. 58-0|이동↑]] Haimovici R, Roussel TJ. Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. Am J Ophthalmol 1989;107:511-514.
# [[임균감염증#cite ref-Treatment of disseminated gonococcal infections. 59-0|이동↑]] Thompson SE. Treatment of disseminated gonococcal infections. Sex Transm Dis 1979;6(Suppl 1):181-184.
# [[임균감염증#cite ref-Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. 60-0|이동↑]] Gaydos CA, Crotchfelt KA, Howell MR, et al. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998;177:417-424.
# [[임균감염증#cite ref-High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. 61-0|이동↑]] Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006;145:564-572.
# [[임균감염증#cite ref-Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. 62-0|이동↑]] Fung M, Scott KC, Kent CK, et al. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007;83:304-309.
# [[임균감염증#cite ref-Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. 63-0|이동↑]] Kissinger PJ, Reilly K, Taylor SN, et al. Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. Sex Transm Dis 2009;36:498- 500.
# [[임균감염증#cite ref-Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. 64-0|이동↑]] Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009;36:478-489.
# [[임균감염증#cite ref-Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. 65-0|이동↑]] Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005;352:676-685.
# [[임균감염증#cite ref-Patient-delivered partner treatment for male urethritis: a randomized.2C controlled trial. 66-0|이동↑]] Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005;41:623-629.

참고문헌 임균감염증 - 편집 역사

Sjlee: 새 문서: # 질병관리본부. 우리나라 성병 감시체계 및 국내 발생 현황. 질병관리본부; 2008. # 임균감염증#cite ref-.ED.95.9C.EA.B5.AD.EC.97.90.EC.84.9C .EB.B6.84...